Logo image of SOL

EMEREN GROUP LTD (SOL) Stock Fundamental Analysis

NYSE:SOL - US75971T3014 - ADR

1.82 USD
0 (0%)
Last: 8/29/2025, 8:04:00 PM
1.8496 USD
+0.03 (+1.63%)
After Hours: 8/29/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, SOL scores 4 out of 10 in our fundamental rating. SOL was compared to 53 industry peers in the Construction & Engineering industry. While SOL seems to be doing ok healthwise, there are quite some concerns on its profitability. SOL scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SOL had positive earnings in the past year.
In the past year SOL had a positive cash flow from operations.
In multiple years SOL reported negative net income over the last 5 years.
SOL had a negative operating cash flow in each of the past 5 years.
SOL Yearly Net Income VS EBIT VS OCF VS FCFSOL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

SOL has a Return On Assets of -1.08%. This is in the lower half of the industry: SOL underperforms 67.92% of its industry peers.
Looking at the Return On Equity, with a value of -1.65%, SOL is doing worse than 67.92% of the companies in the same industry.
Industry RankSector Rank
ROA -1.08%
ROE -1.65%
ROIC N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
SOL Yearly ROA, ROE, ROICSOL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Gross Margin, with a value of 26.87%, SOL is in the better half of the industry, outperforming 77.36% of the companies in the same industry.
SOL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for SOL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
SOL Yearly Profit, Operating, Gross MarginsSOL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

5

2. Health

2.1 Basic Checks

SOL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SOL has been reduced compared to 1 year ago.
The number of shares outstanding for SOL has been increased compared to 5 years ago.
SOL has a worse debt/assets ratio than last year.
SOL Yearly Shares OutstandingSOL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SOL Yearly Total Debt VS Total AssetsSOL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SOL has an Altman-Z score of -0.47. This is a bad value and indicates that SOL is not financially healthy and even has some risk of bankruptcy.
SOL has a worse Altman-Z score (-0.47) than 86.79% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that SOL is not too dependend on debt financing.
SOL has a Debt to Equity ratio of 0.17. This is in the better half of the industry: SOL outperforms 77.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -0.47
ROIC/WACCN/A
WACC10.49%
SOL Yearly LT Debt VS Equity VS FCFSOL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

SOL has a Current Ratio of 4.03. This indicates that SOL is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SOL (4.03) is better than 100.00% of its industry peers.
A Quick Ratio of 4.03 indicates that SOL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.03, SOL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 4.03
SOL Yearly Current Assets VS Current LiabilitesSOL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 215.38% over the past year.
SOL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.85%.
SOL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.02% yearly.
EPS 1Y (TTM)215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5500%
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-57.14%

3.2 Future

SOL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.80% yearly.
SOL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.79% yearly.
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SOL Yearly Revenue VS EstimatesSOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
SOL Yearly EPS VS EstimatesSOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.04, the valuation of SOL can be described as very cheap.
Based on the Price/Earnings ratio, SOL is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
SOL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.13.
Based on the Price/Forward Earnings ratio of 8.79, the valuation of SOL can be described as reasonable.
Based on the Price/Forward Earnings ratio, SOL is valued cheaper than 98.11% of the companies in the same industry.
SOL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 4.04
Fwd PE 8.79
SOL Price Earnings VS Forward Price EarningsSOL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SOL.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.36
SOL Per share dataSOL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SOL's earnings are expected to grow with 72.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y72.8%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SOL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMEREN GROUP LTD

NYSE:SOL (8/29/2025, 8:04:00 PM)

After market: 1.8496 +0.03 (+1.63%)

1.82

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-19 2025-08-19/amc
Earnings (Next)11-12 2025-11-12/amc
Inst Owners42.92%
Inst Owner Change0.19%
Ins Owners1.06%
Ins Owner Change0%
Market Cap93.41M
Analysts80
Price Target4.59 (152.2%)
Short Float %18.9%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-92.82%
Min EPS beat(2)-384.65%
Max EPS beat(2)199.01%
EPS beat(4)2
Avg EPS beat(4)-67.17%
Min EPS beat(4)-384.65%
Max EPS beat(4)199.01%
EPS beat(8)3
Avg EPS beat(8)-824.63%
EPS beat(12)4
Avg EPS beat(12)-552.14%
EPS beat(16)6
Avg EPS beat(16)-418.14%
Revenue beat(2)0
Avg Revenue beat(2)-27.74%
Min Revenue beat(2)-40.72%
Max Revenue beat(2)-14.76%
Revenue beat(4)1
Avg Revenue beat(4)-16.47%
Min Revenue beat(4)-51.47%
Max Revenue beat(4)41.07%
Revenue beat(8)2
Avg Revenue beat(8)-16.8%
Revenue beat(12)3
Avg Revenue beat(12)-22.58%
Revenue beat(16)3
Avg Revenue beat(16)-24.91%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 4.04
Fwd PE 8.79
P/S 1.09
P/FCF N/A
P/OCF 154.9
P/B 0.31
P/tB 0.31
EV/EBITDA 25.36
EPS(TTM)0.45
EY24.73%
EPS(NY)0.21
Fwd EY11.38%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.01
OCFY0.65%
SpS1.67
BVpS5.92
TBVpS5.92
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -1.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.87%
FCFM N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
F-Score5
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 13.21
Cap/Depr 213.85%
Cap/Sales 18.16%
Interest Coverage N/A
Cash Conversion 15.52%
Profit Quality N/A
Current Ratio 4.03
Quick Ratio 4.03
Altman-Z -0.47
F-Score5
WACC10.49%
ROIC/WACCN/A
Cap/Depr(3y)305.97%
Cap/Depr(5y)240.17%
Cap/Sales(3y)29.54%
Cap/Sales(5y)22.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5500%
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-57.14%
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.27%
OCF growth 3YN/A
OCF growth 5YN/A